Rivastigmine: An open-label observational study of behavioral symptoms identified as most troubling by caregivers of patients with Alzheimer's disease

Journal of the American Psychiatric Nurses Association

Volumn 11, Issue 5, 2005, Pages 293-297

  Lilly, Mary LuAnne ^a   Farlow, Martin R ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Dementia; Problem behaviors; Rivastigmine

Indexed keywords

EID: 27744564294     PISSN: 10783903     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078390305282210     Document Type: Article

References (17)

1. Aalten, P., Vugt, M., Lousberg, R., Korten, E., Jaspers, N., Senden, B., et al. (2003). Behavioral problems in dementia: A factor analysis of the neuropsychiatric inventory. Dementia and Geriatric Cognitive Disorders, 15, 99-105.
2. Cohen, C., Gold, D., Shulman, K., Wortley, J. McDonald, G., & Wargon, M. (1993). Factors determining the decision to institutionalize dementing individuals: A prospective study. The Gerontologist, 33, 714-720.
3. Corey-Bloom, J., Anand, R., & Veach, J., for the ENA 713 B352 Study Group. (1998). A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetyleholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. International Journal of Geriatric Psychopharmacology, 1, 55-65.
4. Dunkin, J., & Anderson-Hanley, C. (1998). Dementia caregiver burden: A review of the literature and guidelines for assessment and intervention. Neurology, 51(Suppl. 1), 53-60.
5. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
6. Grossberg, G. (2002). The ABC of Alzheimer's disease: Behavioral symptoms and their treatment. International Psychogeriatrics, 14S, 27-49.
7. Herrman, N. (2002). Cognitive pharmacotherapy of Alzheimer's disease and other dementias. Canadian Journal of Psychiatry, 47, 715-722.
8. Karlawish, J., Casarett, D., Klocinski, J., & Clark, C. (2001). The relationship between caregivers' global ratings of Alzheimer's disease, patients' quality of life, disease severity, and the caregiving experience. Journal of the American Geriatrics Society, 49, 1066-1070.
9. Mittelman, M., Ferris, S., Shulman, E., Steinberg, G., & Levin, B. (1996). A family intervention to delay nursing home placement of patients with Alzheimer disease. Journal of the American Medical Association, 276, 1725-1731.
10. Murman, D., Chen, Q., Powell, M., Kuo, S., Bradley, C., & Colenda, C. (2002). The incremental direct costs associated with behavioral symptoms in AD. Neurology, 59, 1721-1729.
11. Norton, L., Malloy, P., & Salloway, S. (2001). The impact of behavioral symptoms on activities of daily living in patients with dementia. American Journal of Geriatric Psychiatry, 9, 41-48.
12. Reisberg, B., & Ferris, S. (1994). CIBIC-Plus interview guide. East Hanover, NJ: Sandoz Pharmaceuticals.
13. Reisberg, B., Ferris, S., deLeon, M., & Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 1136-1139.
14. Reisberg, B., Sclan, S., Franssen, E., Kluger, A., & Ferris, S. (1994). Dementia staging in chronic care populations. Alzheimer Disease and Associated Disorders, 8(Suppl. 1), S188-S205.
15. Small, G., McDonnell, D., Brooks, R., & Papadopoulos, G. (2002). The impact of symptom severity on the cost of Alzheimer's disease. Journal of the American Geriatric Society, 50, 321-327.
16. Trinh, N., Hoblyn, J., Mohanty, S., & Yaffe, K. (2003). Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: A meta-analysis. Journal of the American Medical Association, 289, 210-216.
17. Yaffe, K., Fox, P., Newcomer, R., Sands, L., Lindquist, K., Dane, K., et al. (2002). Patient and caregiver characteristics and nursing home placement in patients with dementia. Journal of the American Medical Association, 287, 2090-2097.